Envigo Strikes Latest Deal With A PE-Backed Acquisition Co.

By Adam Rhodes (August 21, 2017, 3:44 PM EDT) -- An Avista Capital Holdings-backed special purpose acquisition company announced Monday its bid to combine with Envigo International, a products and research services provider to pharmaceutical and other companies, to create an entity valued at $924 million, the latest in a string of similar deals made in the past week.

Private equity-backed Avista Healthcare Public Acquisition Corp. jointly announced the deal with New Jersey-based Envigo International Holdings Inc., under which Envigo will become a subsidiary of AHPAC. After the deal closes, AHPAC will be renamed Envigo International Holdings Inc., according to the announcement, and is expected to be publicly traded on the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!